Sodium glucose transporter 2 (SGLT2) inhibition with empagliflozin improves cardiac diastolic function in a female rodent model of diabetes

Habibi, Javad ; Aroor, Annayya R ; Sowers, James R ; Jia, Guanghong ; Hayden, Melvin R ; Garro, Mona ; Barron, Brady ; Mayoux, Eric ; Rector, R Scott ; Whaley-Connell, Adam ; DeMarco, Vincent G

Cardiovascular diabetology, 2017-01, Vol.16 (1), p.9-9, Article 9 [Periódico revisado por pares]

England: BioMed Central

Texto completo disponível